Table of Contents:
  • The advent of type-specific antipneumococcal serotherapy
  • A "specific" specific and the turbid age of applied immunology
  • Fundamental tensions: clinical "proof" and clinical resistance
  • The Massachusetts experiment and New (York) tensions
  • The new standard, the new deal, and the pneumonia control programs
  • Histology of a revolution
  • A "modern" revolution: the limits and uses of controlled clinical trials
  • The dismantling of pneumonia as a public health concern.